False Neurochemical Transmitters
Authors: ROBERT A. COHEN
Journal: Annals of Internal Medicine (1966)

Clinical Staff Conference1 August 1966False Neurochemical TransmittersCombined Clinical Staff Conference at the National Institutes of HealthROBERT A. COHEN, M.D., IRWIN J. KOPIN, M.D., CYRUS R. CREVELING, PH.D., JOSE M. MUSACCHIO, M.D., JOSEF E. FISCHER, M.D., J. RICHARD CROUT, M.D., JOHN R. GILL JR., M.D.ROBERT A. COHEN, M.D.Search for more papers by this author, IRWIN J. KOPIN, M.D.Search for more papers by this author, CYRUS R. CREVELING, PH.D.Search for more papers by this author, JOSE M. MUSACCHIO, M.D.Search for more papers by this author, JOSEF E. FISCHER, M.D.Search for more papers by this author, J. RICHARD CROUT, M.D.Search for more papers by this author, JOHN R. GILL JR., M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-2-347 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDr. Robert A. Cohen: Until the happy day when someone comes up with a truly integrated theory, our Institute has followed the pattern of presenting alternately studies of psychosocial and biological aspects of behavior. In this Conference it is the turn for one of the latter. Dr. Irwin J. Kopin, Chief of the Section on Medicine, Laboratory of Clinical Science, National Institute of Mental Health, will report on some of his work relating to the sympathetic nervous system. Dr. Kopin has been interested in the synthesis, storage, release, metabolism, and mode of action of the biogenic amines and has studied...References1. BURGENBURKEDESBARATS-SCHONBAUM ASGML: The specificity of brain choline acetylase. Brit. J. Pharmacol. 11: 308, 1956. Google Scholar2. BOWMANRAND WCMJ: Actions of triethylcholine on neuromuscular transmission. Brit. J. Pharmacol. 17: 176, 1961. Google Scholar3. CARLSSONLINDQVIST AM: In-vivo decarboxylation of α-methyl DOPA and α-methyl metatyrosine. Acta Physiol. Scand. 54: 87, 1962. CrossrefMedlineGoogle Scholar4. DAYRAND MDMJ: A hypothesis for the mode of α-methyldopa in relieving hypertension. J. Pharm. Pharmacol. 15: 221, 1963. CrossrefMedlineGoogle Scholar5. MUSCHOLLMAÎTRE EL: Release by sympathetic stimulation of α-methylnoradrenaline stored in the heart after administration of α-methyldopa. Experientia 19: 658, 1963. CrossrefMedlineGoogle Scholar6. EULER US: Noradrenaline. Charles C Thomas, Publisher, Springfield, Ill., 1956. Google Scholar7. NAGATSULEVITTUDENFRIEND TMS: Tyrosine hydroxylase. J. Biol. Chem. 239: 2910, 1964. CrossrefMedlineGoogle Scholar8. LOVENBERGWEISSBACHUDENFRIEND WHS: Aromatic L-amino acid decarboxylase. J. Biol. Chem. 237: 89, 1962. CrossrefMedlineGoogle Scholar9. LEVINKAUFMAN EYS: Studies on the enzyme catalyzing the conversion of 3, 4-dihydroxyphenylethylamine to norepinephrine. J. Biol. Chem. 236: 2043, 1961. CrossrefMedlineGoogle Scholar10. FRIEDMANKAUFMAN SS: Dopamine-β hydroxylase. Pharmacol. Rev. 17: 71, 1965. MedlineGoogle Scholar11. CREVELINGDALYWITKOPUDENFRIEND CRJWBS: Substrates and inhibitors of dopamine-β-oxidase. Biochim. Biophys. Acta 64: 125, 1962. CrossrefMedlineGoogle Scholar12. CREVELINGDALY CRJW: Unpublished data. Google Scholar13. DALYCREVELINGWITKOP JWCRB: Chemorelease of norepinephrine from the rat heart. J. Med. Chem. 9: 273, 1966. CrossrefMedlineGoogle Scholar14. POTTERAXELROD LTJ: Subcellular localization of catecholamines in tissues of the rat. J. Pharmacol. Exp. Ther. 142: 291, 1963. MedlineGoogle Scholar15. MUSACCHIOKOPINSNYDER JIJS: Effects of disulfiram on tissue norepinephrine content and subcellular distribution of dopamine, tyramine and their β-hyroxylated metabolites. Life Sci. 3: 769, 1964. CrossrefGoogle Scholar16. CARLSSONWALDECK AB: β-Hydroxylation of tyramine in vivo. Acta Pharmacol. (Kobenhavn) 20: 371, 1964. CrossrefGoogle Scholar17. FISCHERMUSACCHIOKOPINAXELROD JEJIJJ: Effects of denervation on the uptake and β-hydroxylation of tyramine in the rat salivary gland. Life Sci. 3: 413, 1964. CrossrefGoogle Scholar18. MUSACCHIOKOPINWEISE JIJVK: Subcellular distribution of some sympathomimetic amines and their β-hydroxylated derivatives in rat heart. J. Pharmacol. Exp. Ther. 148: 22, 1965. MedlineGoogle Scholar19. MUSACCHIOFISCHERKOPIN JJEIJ: Effect of chronic sympathetic denervation on subcellular distribution of some sympathomimetic amines. Biochem. Pharmacol. 14: 898, 1965. CrossrefMedlineGoogle Scholar20. MUSACCHIOFISCHERKOPIN JJEIJ: Subcellular distribution and release of dopamine- and α-methyldopamine. J. Pharmacol. Exp. Ther. 152: 51, 1966. MedlineGoogle Scholar21. FISCHERHORSTKOPIN JEWDIJ: β-Hydroxylated sympathomimetic amines as false neurotransmitters. Brit. J. Pharmacol. 24: 477, 1965. Google Scholar22. GESSACOSTAKUNTZMANBRODIE GLERBB: On the mechanism of norepinephrine release by α-methyl-metatyrosine. Life Sci. 1: 353, 1962. CrossrefGoogle Scholar23. SHOREBUSFIELDALPERS PADHS: Binding and release of metaraminol: mechanism of norepinephrine depletion by α-methyl-mtyrosine and related agents. J. Pharmacol. Exp. Ther. 146: 194, 1964. MedlineGoogle Scholar24. ANDÉN N: On the mechanism of noradrenaline depletion by α-methyl metatyrosine and metaraminol. Acta Pharmacol. (Kobenhavn) 21: 260, 1964. CrossrefMedlineGoogle Scholar25. UDENFRIENDZALTZMAN-NIRENBERG SP: On the mechanism of the norepinephrine release produced by α-methyl-meta-tyrosine. J. Pharmacol. Exp. Ther. 138: 194, 1962. MedlineGoogle Scholar26. CROUTALPERSTATUMSHORE JRHSELPA: Release of metaraminol (Aramine) from the heart by sympathetic nerve stimulation. Science 145: 828, 1964. CrossrefMedlineGoogle Scholar27. HARRISONCHIDSEYBRAUNWALD DCCAE: Studies on the mechanism of action of metaraminol (Aramine). Ann. Intern. Med. 59: 297, 1963. LinkGoogle Scholar28. PETTINGERSPECTORHORWITZSJOERDSMA WASDA: Restoration of tyramine pressor responses in reserpine-treated animals by methyldopa and its amine metabolites. Proc. Soc. Exp. Biol. Med. 118: 988, 1965. CrossrefMedlineGoogle Scholar29. MASONBRAUNWALD DTE: Effects of guanethidine, reserpine and methyldopa on reflex venous and arterial constriction in man. J. Clin. Invest. 43: 1449, 1964. CrossrefMedlineGoogle Scholar30. CHENWUHENRIKSEN KKCKE: Relationship between the pharmacological action and the chemical constitution and configuration of the optical isomers of ephedrine and related compounds. J. Pharmacol. Exp. Ther. 36: 363, 1929. Google Scholar31. OHLERWAKERLIN EAGE: Amines in experimental hypertensions. Circ. Res. 1: 122, 1953. CrossrefMedlineGoogle Scholar32. HORWITZSJOERDSMA DA: A basis for the use of monoamine oxidase inhibitors in angina pectoris. Ann. N. Y. Acad. Sci. 107: 1033, 1963. CrossrefMedlineGoogle Scholar33. ORVISTAMAGNAHORWITZTHOMAS HHIGDR: Correlation of hypotensive effects and urinary tryptamine levels during pargyline therapy. Ibid., p. 958. Google Scholar34. ZELLER EA (editor): New reflections on monoamine oxidase inhibition. Ibid. p. 809. Google Scholar35. The cheese reaction (editorial). Lancet 2: 540, 1964. Google Scholar36. KAKIMOTOARMSTRONG YMD: On the identification of octopamine in mammals. J. Biol. Chem. 237: 422, 1962. CrossrefMedlineGoogle Scholar37. KOPINFISCHERMUSACCHIOHORSTWEISE IJJEJMWDVK: False neurochemical transmitters and the mechanism of sympathetic blockade by monoamine oxidase inhibitors. J. Pharmacol. Exp. Ther. 147: 186, 1965. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: This is an edited transcription of a combined clinical staff conference at the Clinical Center, Bethesda, Md., by the National Institute of Mental Health, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare.Requests for reprints should be addressed to Robert A. Cohen, M.D., Clinical Director, National Institute of Mental Health, Bldg. 10, Rm. 3-N-234, National Institutes of Health, Bethesda, Md. 20014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDirect-Acting Smooth Muscle Vasodilators and Adrenergic InhibitorsDisorders of Potassium MetabolismPotassium and anaesthesiaAmino acids and hepatic encephalopathyMedical Treatment of Renal HypertensionAcute Liver Failure and EncephalopathyAntihypertensive Drugs: Clinical Pharmacology and Therapeutic UseSerum octopamine, coma, and charcoal haemoperfusion in fulminant hepatic failurePlatelet Uptake of Octopamine and Norepinephrine in Hepatic EncephalopathyHypertyraminemia in Cirrhotic PatientsLa Sindrome Epato-RenaleURINARY AND SERUM OCTOPAMINE IN PATIENTS WITH PORTAL-SYSTEMIC ENCEPHALOPATHYRole of a False Neurotransmitter, Octopamine, in the Pathogenesis of Hepatic and Renal EncephalopathyAscites: Pathogenesis and TreatmentMedical Management of Primary HypertensionOxydationsprodukte von 6-Hydroxy-dopaminNew directions in the chemistry of natural products: The organic chemist as a pathfinder for biochemistry and medicineFALSE NEUROTRANSMITTERS AND HEPATIC FAILUREPotassium-retaining diuretics: Electrolyte changes induced in hypertensive patientsPseudo-AntialdosteroneApplication of Tracer Methodology to the Study of Biogenic AminesDIURETIC-INDUCED HYPERKALÆMIAA CHEAP DISPOSABLE PIPETTEHYPERTENSIVE ANGIOPATHY IN FAMILIAL CHLORIDE DIARRHŒADIURETIC-INDUCED HYPERKALÆMIAHYPERURICÆMIA AND VASCULAR DISEASEPROGNOSIS OF SARCOIDOSISChapter 2. Antidepressants, Stimulants, Hallucinogens 1 August 1966Volume 65, Issue 2Page: 347-362KeywordsBehaviorBlood plasmaClinical laboratory sciencesMedical servicesPrevention, policy, and public healthPsychiatry and mental healthResearch laboratoriesSympathetic nervous system ePublished: 1 December 2008 Issue Published: 1 August 1966 PDF downloadLoading ...